Deutsche Bank AG reiterated their buy rating on shares of Walgreens Boots Alliance Inc. (NASDAQ:WBA) in a research report released on Thursday. Deutsche Bank AG currently has a $88.00 price objective on the pharmacy operator’s stock.

Several other analysts have also recently commented on WBA. Jefferies Group set a $95.00 price objective on shares of Walgreens Boots Alliance and gave the company a buy rating in a research note on Sunday, October 23rd. Credit Suisse Group AG reiterated an outperform rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Friday, October 21st. Barclays PLC set a $79.00 target price on shares of Walgreens Boots Alliance and gave the company a hold rating in a research note on Friday, October 21st. Leerink Swann set a $90.00 target price on shares of Walgreens Boots Alliance and gave the company a buy rating in a research note on Tuesday, November 8th. Finally, Robert W. Baird reiterated an outperform rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Saturday, September 10th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fourteen have given a buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus target price of $90.30.

Walgreens Boots Alliance (NASDAQ:WBA) opened at 81.76 on Thursday. Walgreens Boots Alliance has a 52-week low of $71.50 and a 52-week high of $87.05. The company has a market cap of $88.57 billion, a price-to-earnings ratio of 21.40 and a beta of 1.19. The firm’s 50-day moving average is $80.50 and its 200 day moving average is $80.87.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, October 20th. The pharmacy operator reported $1.07 EPS for the quarter, beating the consensus estimate of $0.99 by $0.08. Walgreens Boots Alliance had a net margin of 3.56% and a return on equity of 16.33%. The business earned $28.60 billion during the quarter, compared to analysts’ expectations of $29.06 billion. During the same period in the previous year, the business posted $0.88 EPS. The business’s quarterly revenue was up .4% compared to the same quarter last year. On average, equities research analysts predict that Walgreens Boots Alliance will post $5.01 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, December 12th. Shareholders of record on Thursday, November 17th will be paid a $0.375 dividend. The ex-dividend date is Tuesday, November 15th. This represents a $1.50 annualized dividend and a yield of 1.83%. Walgreens Boots Alliance’s dividend payout ratio is currently 39.27%.

In other news, Director William C. Foote sold 2,067 shares of the firm’s stock in a transaction that occurred on Wednesday, November 2nd. The shares were sold at an average price of $81.30, for a total transaction of $168,047.10. Following the transaction, the director now directly owns 24,623 shares in the company, valued at $2,001,849.90. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Kathleen Wilson-Thompson sold 23,996 shares of the firm’s stock in a transaction that occurred on Thursday, September 8th. The stock was sold at an average price of $85.00, for a total transaction of $2,039,660.00. The disclosure for this sale can be found here. 21.10% of the stock is currently owned by company insiders.

Institutional investors have recently made changes to their positions in the company. M&R Capital Management Inc. increased its stake in shares of Walgreens Boots Alliance by 6.1% in the first quarter. M&R Capital Management Inc. now owns 8,760 shares of the pharmacy operator’s stock valued at $738,000 after buying an additional 501 shares in the last quarter. Squarepoint Ops LLC increased its stake in shares of Walgreens Boots Alliance by 12.0% in the first quarter. Squarepoint Ops LLC now owns 10,684 shares of the pharmacy operator’s stock valued at $900,000 after buying an additional 1,143 shares in the last quarter. Deerfield Management Co. increased its stake in shares of Walgreens Boots Alliance by 32.3% in the first quarter. Deerfield Management Co. now owns 511,457 shares of the pharmacy operator’s stock valued at $43,085,000 after buying an additional 125,000 shares in the last quarter. Banbury Partners LLC increased its stake in shares of Walgreens Boots Alliance by 27.3% in the first quarter. Banbury Partners LLC now owns 209,537 shares of the pharmacy operator’s stock valued at $17,651,000 after buying an additional 45,000 shares in the last quarter. Finally, LPL Financial LLC increased its stake in shares of Walgreens Boots Alliance by 9.2% in the first quarter. LPL Financial LLC now owns 598,159 shares of the pharmacy operator’s stock valued at $49,863,000 after buying an additional 50,306 shares in the last quarter. Institutional investors and hedge funds own 60.36% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.